Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07462767 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Precision Microbiota Interventions for Senoreduction Trial

Study acronym: PreMIS
StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Apr 1, 2026 to Oct 1, 2026
    • Eligibility criteria expanded, about 8 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
Trial Details
NCT Number NCT07462767
Lead Sponsor Louisiana State University Health Sciences Center in New Orleans
Conditions
(from sponsor)		 HIV Infections, Alcohol Drinking, Aging, Immunosenescence
Related terms Alcohol Drinking, HIV Infections
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov